The construction of male menopause in Finnish popular magazines

Critical Public Health

Volumn 16, Issue 1, 2006, Pages 19-34

  Vainionpää, Kirsi ^a   Topo, Päivi ^b  

^a UNIVERSITY OF LAPLAND   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Health consumerism; Male hormone therapy; Male menopause; Medicalization

Indexed keywords

TESTOSTERONE;

AGING; ARTICLE; CARDIOVASCULAR DISEASE; CONSUMER HEALTH INFORMATION; DISEASE ASSOCIATION; DRUG INDICATION; DRUG MARKETING; FINLAND; HORMONAL THERAPY; HUMAN; MALE; MALE MENOPAUSE; MASS MEDIUM; MEDICAL EXPERT; MENOPAUSAL SYNDROME; PROSTATE CANCER; PROSTATE HYPERTROPHY; PUBLICATION; SOCIAL PROBLEM; SYMPTOMATOLOGY; TESTOSTERONE BLOOD LEVEL; TREATMENT DURATION;

EID: 33744817679     PISSN: 09581596     EISSN: 14693682     Source Type: Journal    
DOI: 10.1080/09581590600601882     Document Type: Article

References (70)

1. Ayuso-Mateos, JL and Dowrick, C and Lehtinen, V and Dalgard, OS and Casey, P and Wilkinson, C and (2001) Depressive disorders in Europe: Prevalence figures from the ODIN study British Journal of Psychiatry, 179, pp. 308-316.
2. Ballinger, B. (1990) Psychiatric aspects of the menopause British Journal of Psychiatry, 156, pp. 773-787.
3. Basaria, S and Dobs, AS. (2001) Hypogonadism and androgen replacement therapy in elderly men American Journal of Medicine, 110, pp. 563-572.
4. Beetham, M.(1996) A magazine of her own? domesticity and desire in the women's magazines, 1800-1914. London: Routledge.
5. Bell, SE. (1987) The medicalization of menopause Social Science and Medicine, 24(6), pp. 535-542.
6. Bordo, S.(1993) Unbearable weight: Feminism, western culture and the body. Berkeley: University of California Press.
7. Bordo, S.(1999) The male body: A new look at men in public and private. New York Farrar: Straus & Giroux.
8. Briggs, R.(1990) Biological ageing. In Ageing in society: An introduction to social gerontology. London: Sage Publications.
9. Bunton, R.(1998) Popular health and advanced liberalism and Good Housekeeping magazine. In Foucault, health and medicine. London and New York: Routledge.
10. Bunton, R and Crawshaw, P.(2002) Consuming men's health: Risk, ritual and ambivalence in men's lifestyle magazines. In Consuming health: The commodification of health care. London and New York: Routledge.
11. Carter, MJ.(2000) Mediating medicine: Controversy, credibility, and the use of alternatives to conventional hormone therapy. In PhD thesis. University of Oregon.
12. Cole, TR and Thompson, B. (2001) Anti-aging: Are you for it or against it? Generations, Journal of the American Society on Aging, 25(4), pp. 6-8. Special Issue
13. Coney, S.(1994) The menopause industry. Alameda CA: Hunter House.
14. Conrad, P and Schneider, JW.(1980a) Deviance and medicalization: From badness to sickness. St Louis: C.V. Mosby.
15. Conrad, P and Schneider, JW. (1980b) Looking at levels of medicalization: A comment on Strong's critique of the thesis of medical imperialism Social Science and Medicine, 14A, pp. 75-79.
16. Conrad, P. (1992) Medicalization and social control Annual Review of Sociology, 18, pp. 209-232.
17. Conrad, P and Potter, D. (2000) From hyperactive children to ADHD adults: Observations on the expansion of medical categories Social Problems, 47, pp. 559-582.
18. Farrant, W and Russell, J.(1986) The politics of health information. London: Health Education Council.
19. Featherstone, M and Hepworth, M. (1985) The male menopause: Lifestyle and sexuality Maturitas, 7, pp. 235-246.
20. Featherstone, M.(1991) The body in consumer culture. In The body: Social process and cultural theory. London Newbury Park and New Delhi: Sage Publications.
21. Finnish Medical Association. (2001). A press release on andrology subspecialty. Available at:, page (accessed 4 December 2001)
22. Fitzpatrick, M.(2001) The tyranny of health: Doctors and the regulation of lifestyle. London and New York: Routledge.
23. Grady, D and Herrington, D and Bittner, V and Blumenthal, R and Davidson, M and (2002) Cardiovascular disease outcomes during 6.8 years of hormone therapy. Heart and estrogen/progestin replacement study follow-up (HERS II) Journal of the American Medical Association, 288, pp. 49-57.
24. Gonyea, JG. (1998) Midlife and menopause: Uncharted territories for baby boomer women Generations, Journal of the American Society on Aging, 22(1), pp. 87-89.
25. Goodwin, JS. (2001) Narcissus drowned Lancet, 357, pp. 1376-1377.
26. Gould, DC and Petty, R and Jacobs, HS. (2000) The male menopause - does it exist? British Medical Journal, 320, pp. 858-861.
27. Griffiths, F. (1999) Women's control and choice regarding HRT Social Science & Medicine, 49, pp. 469-481.
28. Helén, I. (2002) Lääketieteen lupaus ja elämän politiikka Sosiologia, 2, pp. 104-115.
29. Hemminki, E. (2002) Vaihdevuosien hormonilääkityksen opetus: Päättely ei voi korvata kokeellista tutkimusta lääkehoidossa Suomen Lääkärilehti, 38, pp. 3701.
30. Henderson, S and Petersen, A.(2002) Consumerism in health care. In Consuming health: The commodification of health care. London and New York: Routledge.
31. Hepworth, M.(1995) Positive ageing: What is the message. In The sociology of health promotion: Critical analyses of consumption, lifestyle and risk. London and New York: Routledge.
32. Hepworth, M and Featherstone, M.(1998) The male menopause: Lay accounts and the cultural reconstruction of midlife. In The body in everyday life. London and New York: Routledge.
33. Hoffmann, AR. (2001) Should we treat the andropause? American Journal of Medicine, 111(4), pp. 322-323.
34. Järvi, U. (2002) Suomalaisgynekologit kaipaavat haitoista lisätutkimuksia. Hormonikorvaushoitoa vain vaihdevuosioireista kärsiville Suomen Lääkärilehti, 30-32, pp. 2982-2984.
35. Karpf, A.(1988) Doctoring the media: The reporting of health and medicine. London: Routledge.
36. Kaufert, PA and Lock, M. (1997) Medicalization of women's third age Journal of Psychosomatic Obstetrics and Gynecology, 18(2), pp. 81-86.
37. Kolata, G. (2002) Male hormone therapy popular but untested New York Times, pp. 1.
38. Lacey, JV and Mink, PJ and Lubin, JH and Sherman, ME and Troisi, R and Hartge, P and (2002) Menopausal hormone replacement therapy and risk of ovarian cancer Journal of the American Medical Association, 288, pp. 334-341.
39. Lupton, D.(1995) The imperative of health: Public health and the regulated body. London Thousand Oaks and New Delhi: Sage Publications.
40. Lövdahl, U and Riska, E. (2000) The construction of gender and mental health in Nordic psychotropic-drug advertising International Journal of Health Services, 30, pp. 387-406.
41. Mazur, A and Booth, A. (1998) Testosterone and dominance in men Behavioral and Brain Sciences, 21, pp. 353-397.
42. Monaghan, E and Glickman, S.(1992) Hormones and aggressive behavior. In Behavioral endocrinology. Cambridge MA: MIT Press.
43. Morales, A and Heaton, JP and Carson, CC, III. (2000) Andropause: A misnomer for a true clinical entity Journal of Urology, 163, pp. 705-712.
44. Muhr, T.(1997) Scientific software development's ATLAS.TI. The knowledge workbench. In Short user's manual. Berlin Available at: (accessed 2 December 2002)
45. National Agency for Medicines. (2002). Statistics. Available at: (accessed 1 December 2002)
46. National Agency for Medicines. (2004). Statistics. Available at: (accessed 25 May 2004)
47. National Public Health Institute. (2002). Health 2000 Basic Report. Available at: (accessed 10 January 2003)
48. Niskanen, P and Mikkonen, T. (1999) Masennus ja työkyvyttömyys Suomen Lääkärilehti, 54, pp. 3823-3827.
49. Oinas, E. (1998) Medicalisation by whom? Accounts of menstruation conveyed by young women and medical experts in medical advisory columns Sociology of Health and Illness, 20, pp. 52-70.
50. Organon. (2003). A website for andropause information. Available at: (accessed 10 January 2003)
51. Oudshoorn, NEJ. (1997) Menopause, only for women? The social construction of menopause as an exclusively female condition Journal of Psychosomatic Obstetrics and Gynecology, 18, pp. 137-144.
52. Paul, R. (2002) Hormonikorvaushoito - quo vadis? Suomen Lääkärilehti, 27-29, pp. 2897.
53. Petersen, A. (1994) Governing images: Media constructions of the 'normal', 'healthy' subject Media Information Australia, 72, pp. 32-40.
54. Pharma Facts Finland 2001.(2001) Helsinki: Pharmaceutical Information Center.
55. Pharma Facts Finland. 2002.(2002) Helsinki: Pharmaceutical Information Center.
56. Riessman, CK. (1983) Women and medicalization: A new perspective Social Policy, 14, pp. 3-18.
57. Rose, N.(1999) Powers of freedom. Reframing political thought. Cambridge: Cambridge University Press.
58. Schwartz, LM and Woloshin, S. (1999) Changing disease definitions: Implications for disease prevalence. Analysis of the third national health and nutrition examination survey, 1988-1998 Effective Clinical Practice, 2, pp. 76-85.
59. Tapanainen, J. (2001) Andropaussi Duodecim, 117, pp. 1974-1979.
60. Tiefer, L. (1996) The medicalisation of sexuality: Conceptual, normative and professional issues Annual Review of Sex Research, 7, pp. 252-282.
61. Topo, P and Klaukka, T and Hemminki, E and Uutela, A. (1991) Use of hormone replacement therapy in 1976-89 by 45-64-year-old Finnish women Journal of Epidemiology and Community Health, 45, pp. 277-280.
62. Topo, P. (1997) Climacteric hormone therapy in medical and lay texts in Finland from 1955 to 1992 Social Science and Medicine, 45, pp. 751-760.
63. Turner, BS.(1992) Regulating bodies: Essays in medical sociology. London and New York: Routledge.
64. Turner, BS.(1995) Medical power and social knowledge 2nd ed. London: Sage.
65. US Department of Health and Human Services National Institutes of Health. (2002). Press Release. Available at: (accessed 15 December 2002)
66. US National Library of Medicine and the National Institutes of Health. (2002). Press Release. Available at: (accessed 27 November 2002)
67. Varjonen, J and Romanov, K and Kaprio, J and Heikkilä K and Koskenvuo, M. (1997) Self-rated depression in 12,063 middle-aged adults Nordic Journal of Psychiatry, 51, pp. 331-338.
68. Vermeulen, A. (2000) Andropause Maturitas, 34, pp. 5-15.
69. Writing Group for the Women's Health Initiative Investigators. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the women's health initiative randomized controlled trial Journal of the American Medical Association, 288, pp. 321-333.
70. Zola, IK. (1972) Medicine as an institution of social control Sociological Review, 20, pp. 487-504.